Tag: Health

eli-lilly-to-test-obesity-medications-for-alcohol-and-drug-addiction-ceo-announces-study

Eli Lilly to Test Obesity Medications for Alcohol and Drug Addiction: CEO Announces Study

Eli Lilly Breaks New Ground in Addiction Treatment ResearchEli Lilly, the pharmaceutical giant behind the popular weight loss drug Zepbound, has made a groundbreaking announcement. The company is set to embark on a study...
news-15112024-041859

Reaction to Trump’s selection of RFK Jr. for HHS leadership

Leaders in the biopharma world and scientific community were taken aback by the news that President-elect Donald Trump has chosen Robert F. Kennedy Jr. to lead the Department of Health and Human Services. This...
news-26112024-115233

Roche Lung Cancer Study: Immunotherapy Failures and Drug Target Questions

Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a major lung cancer study. The study, known as SKYSCRAPER-01, involved...
news-08112024-220349

Inside the Therapist’s Room: A Look at the 2024 Election

I stand before my bathroom mirror, trying to calm my breathing. It's the morning after the election, and I just found out the results an hour ago. I've rushed through my morning routine, feeling...
news-22102024-032124

Navigating Ultra-Processed Foods: Dietary Experts’ Advice

Scientific experts working on the development of the 2025-2030 Dietary Guidelines for Americans recently discussed the challenges of including ultra-processed foods due to a lack of a clear definition and limited scientific research on...
news-28112024-120413

Understanding the Urgency of the BIOSECURE Act for Biosecurity Measures

The BIOSECURE Act, a piece of legislation targeting Chinese biotechnology companies, has been the center of attention in Washington early this year. However, the fate of this bill hangs in the balance as Congress...
news-17112024-061144

CRISPR Therapy Shows Superior Benefit for Cardiomyopathy Patients

Intellia Therapeutics CEO John Leonard has been facing a familiar situation for the past few years. The company has been sharing positive results from its gene editing trials, only to see its stock prices...
news-06112024-052955

Pharmacies Sue GoodRx and PBMs for Illegal Reimbursement Fees

Three independent pharmacies recently took legal action against GoodRx, a company that offers a prescription drug discount card, as well as several pharmacy benefit managers (PBMs). These lawsuits allege that GoodRx and the PBMs...
news-14112024-161449

Merck Expands Portfolio with Licensing of Chinese Cancer Drug

Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...
news-18112024-001346

Alzheimer’s Drug Reversal & Bavarian Nordic’s Trump Views: Pharmalittle Update

As the week comes to an end, it's time to start thinking about weekend plans. Whether it's tidying up, taking a trip to see a college campus, or catching up on reading, there are...
top-medical-breakthroughs-of-2024-a-comprehensive-guide-to-the-latest-nnovations

Top Medical Breakthroughs of 2024: A Comprehensive Guide to the Latest Innovations

Top Medical Breakthroughs of 2024: A Comprehensive Guide to the Latest InnovationsIn a year marked by incredible advancements in the field of medicine, 2024 has truly been a game-changer. From cutting-edge treatments for diabetes...
news-19112024-001706

Promising Drugs for Lipoprotein(a) – Reducing Risk of Heart Disease

Lipoprotein(a) is a lesser-known risk factor for heart disease that can be just as dangerous as high cholesterol. This lipoprotein can lead to plaque build-up in arteries, increasing the risk of heart attacks and...